Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 14NIH 4INDUSTRY 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma 32Lymphoma, Follicular 13Lymphoma, Large B-Cell, Diffuse 12Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Mantle-Cell 8Burkitt Lymphoma 8Lymphoma, Non-Hodgkin 4Waldenstrom Macroglobulinemia 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Leukemia 3Lymphoma, B-Cell, Marginal Zone 2Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Myelodysplastic Syndromes 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1

Interventions

Vincristine 4Prednisone 4Methotrexate 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Etoposide 4Doxorubicin 4Cytarabine 4Cyclophosphamide 4Leucovorin 3Methylprednisolone Hemisuccinate 2Methylprednisolone Acetate 2Methylprednisolone 2Hydrocortisone 2rasburicase 1pegfilgrastim 1pegaspargase 1merphos 1liposomal amphotericin B 1imetelstat 1hydrocortisone hemisuccinate 1Vancomycin 1Urate Oxidase 1Traumeel S 1Topotecan 1Thioguanine 1Tazobactam 1Rituximab 1Radiotherapy 1Psychiatric Rehabilitation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Dendritic Cell Sarcoma, Interdigitating × Rituximab × Clear all
NCT00057811 2014-09-19

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

Children's Oncology Group

Phase 2 Completed
97 enrolled 13 charts
LymphoidSarcoma

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡